Why do People With Low Back Pain Fear and Avoid Lifting?

January 28, 2022 updated by: Thomas Matheve, Hasselt University

The investigators' main focus of this trial will be to investigate

  • why people with low back pain perceive lifting (with a bent back) as harmful.
  • whether general measures of pain-related fear are associated with task-specific measures of perceived harmfulness
  • why people with low back pain avoid lifting (with a bent back) This will be investigated using self-report (i.e., questionnaires)

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Interventional

Enrollment (Anticipated)

325

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Hasselt, Belgium, 3500
        • Hasselt University
        • Contact:
        • Contact:
        • Principal Investigator:
          • Thomas Matheve, PhD
        • Principal Investigator:
          • Lotte Janssens, PhD
        • Principal Investigator:
          • Katleen Bogaerts, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • low back pain >3 months

Exclusion Criteria:

  • healthy persons
  • low back pain <3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: LBP
This group will be asked to complete self-reported questionnaires on a single occasion (cross-sectional)

participants in this group will be ask to complete questionnaires on one occasion (i.e., cross-sectional investigation). The questionnaires will consist of a self-developed questionnaire and standard questionnaires. The main aspects of the self-developed questionnaires are

  • perceived harmfulness of activities (selection of PHODA-SeV)
  • cognitions about lifting and pain
  • reasons for avoidance behaviour (lifting)

Standardised questionnaires include

  • NRS for pain
  • TSK-11
  • FABQ
  • RMDQ

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cognitions about perceived harmfulness and avoidance of lifting
Time Frame: Day 1 (cross-sectional study)
cognitions about perceived harmfulness and avoidance of lifting using self-developed questionnaires. Questions will be scored on a 1-5 Likert scale (1= completely disagree, 5= completely agree)
Day 1 (cross-sectional study)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain-related fear
Time Frame: Day 1 (cross-sectional study)
Tampa Scale for Kinesiophobia 11-item version questionaire (range= 11-44. Higher score = higher levels of pain-related fear)
Day 1 (cross-sectional study)
perceived harmfulness of specific tasks
Time Frame: Day 1 (cross-sectional study)
perceived harmfulness of specific tasks measured with a selection of pictures of the Photographs of Daily Activities - Short Electronic version. Each picture will be scored on a 0-100 scale, with higher scores indicating higher levels of perceived harmfulness
Day 1 (cross-sectional study)
Disability
Time Frame: Day 1 (cross-sectional study)
Roland Morris Disability Questionnaire (score range= 0-24, higher score= higher level of disbility)
Day 1 (cross-sectional study)
Task-specific self-efficacy
Time Frame: Day 1 (cross-sectional study)
For different tasks, participants will be asked to rate the task-specific self-efficacy on a 0-10 Visual analogue scale (higher scores= higher levels of self-efficacy)
Day 1 (cross-sectional study)
Task-specific disability
Time Frame: Day 1 (cross-sectional study)
For different tasks, participants will be asked to rate their perceived disability on a 0-10 Visual analogue scale (higher scores= higher levels of disability)
Day 1 (cross-sectional study)
Pain-related fear
Time Frame: Day 1 (cross-sectional study)
Fear-Avoidance Beliefs Questionnaire. The Activity Avoidance Subscale (score range= 0-24) and Work subscale (score range= 0-42) will both be used. Higher scores indicate higher levels of pain-related fear
Day 1 (cross-sectional study)
Pain intensity
Time Frame: Day 1 (cross-sectional study)
Numeric rating scale (0-10, higher score= higher level of pain)
Day 1 (cross-sectional study)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: Day 1 (cross-sectional study)
years
Day 1 (cross-sectional study)
Sex
Time Frame: Day 1 (cross-sectional study)
Male, female, other
Day 1 (cross-sectional study)
Physical job requirements
Time Frame: Day 1 (cross-sectional study)
Questionnaire (derived from de Dutch Musculoskeletal Questionnaire) asking about physical job requirements
Day 1 (cross-sectional study)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas Matheve, PhD, Hasselt University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2022

Primary Completion (Anticipated)

June 30, 2023

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

December 22, 2021

First Submitted That Met QC Criteria

December 30, 2021

First Posted (Actual)

January 14, 2022

Study Record Updates

Last Update Posted (Actual)

February 2, 2022

Last Update Submitted That Met QC Criteria

January 28, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ThomasMatheve-2021-3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Cross-sectional self-report (questionnaires)

3
Subscribe